[SCHEDULE 13G/A] Adicet Bio, Inc. Amended Passive Investment Disclosure
Adicet Bio reported a Schedule 13G/A amendment showing that Woodline Partners beneficially owns 313,124 shares of common stock, representing 3.3% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Adicet Bio reported a Schedule 13G/A amendment showing that Woodline Partners beneficially owns 313,124 shares of common stock, representing 3.3% of the class. The filing cites March 10, 2026 as the outstanding-share anchor of 9,596,407 shares.
The statement lists sole voting and dispositive power over the 313,124 shares by the Woodline Fund. The filing is a passive ownership disclosure filed under the ownership threshold rules rather than an active acquisition or disposition report.
Insights
Woodline reports a passive 3.3% stake in Adicet Bio.
Woodline Partners discloses beneficial ownership of 313,124 shares with sole voting and dispositive power. The percentage is calculated using the issuer's reported outstanding shares of 9,596,407 as of March 10, 2026.
Because this is a Schedule 13G/A amendment, it indicates passive investor status under applicable rules. Subsequent filings would show any change in position or a move to an active filing status.
Filing is a regulatory disclosure of ownership, not an operational action.
The amendment clarifies beneficial ownership and voting/dispositive powers for compliance with Section 13 reporting. It cites a specific outstanding-share figure from the company’s Form 10-K for calculation purposes.
Key compliance elements: CUSIP is provided, the reporting person is named, and signature by counsel certifies the amendment. No proceeds or transactions are disclosed in the excerpt.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Woodline Partners report in Adicet Bio (ACET)?
Is this Schedule 13G/A an active trade or a passive ownership report for ACET?
AI-generated analysis. How Rhea-AI works. Not financial advice.